Number needed to treat for time-to-event data with competing risks

被引:15
作者
Gouskov, Natalia A. [1 ]
Kundu, Suprateek [1 ]
Imrey, Peter B. [2 ]
Fine, Jason P. [1 ]
机构
[1] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[2] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
关键词
competing risks; number needed to treat; time-to-event data; CURVES;
D O I
10.1002/sim.5922
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The number needed to treat is a tool often used in clinical settings to illustrate the effect of a treatment. It has been widely adopted in the communication of risks to both clinicians and non-clinicians, such as patients, who are better able to understand this measure than absolute risk or rate reductions. The concept was introduced by Laupacis, Sackett, and Roberts in 1988 for binary data, and extended to time-to-event data by Altman and Andersen in 1999. However, up to the present, there is no definition of the number needed to treat for time-to-event data with competing risks. This paper introduces such a definition using the cumulative incidence function and suggests non-parametric and semi-parametric inferential methods for right-censored time-to-event data in the presence of competing risks. The procedures are illustrated using the data from a breast cancer clinical trial. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:181 / 192
页数:12
相关论文
共 23 条
[1]   Calculating the number needed to treat for trials where the outcome is time to an event [J].
Altman, DG ;
Andersen, PK .
BRITISH MEDICAL JOURNAL, 1999, 319 (7223) :1492-1495
[2]   Confidence intervals for the number needed to treat [J].
Altman, DG .
BRITISH MEDICAL JOURNAL, 1998, 317 (7168) :1309-1312
[3]  
[Anonymous], 2011, The statistical analysis of failure time data
[4]   Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis [J].
Ben Salah, Afif ;
Ben Messaoud, Nathalie ;
Guedri, Evelyn ;
Zaatour, Amor ;
Ben Alaya, Nissaf ;
Bettaieb, Jihene ;
Gharbi, Adel ;
Hamida, Nabil Belhadj ;
Boukthir, Aicha ;
Chlif, Sadok ;
Abdelhamid, Kidar ;
El Ahmadi, Zaher ;
Louzir, Hechmi ;
Mokni, Mourad ;
Morizot, Gloria ;
Buffet, Pierre ;
Smith, Philip L. ;
Kopydlowski, Karen M. ;
Kreishman-Deitrick, Mara ;
Smith, Kirsten S. ;
Nielsen, Carl J. ;
Ullman, Diane R. ;
Norwood, Jeanne A. ;
Thorne, George D. ;
McCarthy, William F. ;
Adams, Ryan C. ;
Rice, Robert M. ;
Tang, Douglas ;
Berman, Jonathan ;
Ransom, Janet ;
Magill, Alan J. ;
Grogl, Max .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (06) :524-532
[5]  
Breslow N. E., 1972, J R STAT SOC B, V34, P216
[6]   Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection [J].
Climo, Michael W. ;
Yokoe, Deborah S. ;
Warren, David K. ;
Perl, Trish M. ;
Bolon, Maureen ;
Herwaldt, Loreen A. ;
Weinstein, Robert A. ;
Sepkowitz, Kent A. ;
Jernigan, John A. ;
Sanogo, Kakotan ;
Wong, Edward S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (06) :533-542
[7]  
Connor J., 2005, Encyclopedia of Biostatistics, DOI [DOI 10.1002/0470011815.B2A10047, 10.1002/0470011815.b2a10047]
[8]   THE NUMBER NEEDED TO TREAT - A CLINICALLY USEFUL MEASURE OF TREATMENT EFFECT [J].
COOK, RJ ;
SACKETT, DL .
BRITISH MEDICAL JOURNAL, 1995, 310 (6977) :452-454
[9]   ADJUVANT TAMOXIFEN VERSUS PLACEBO IN ELDERLY WOMEN WITH NODE-POSITIVE BREAST-CANCER - LONG-TERM FOLLOW-UP AND CAUSES OF DEATH [J].
CUMMINGS, FJ ;
GRAY, R ;
TORMEY, DC ;
DAVIS, TE ;
VOLK, H ;
HARRIS, J ;
FALKSON, G ;
BENNETT, JM .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) :29-35
[10]  
Fine J P, 2001, Biostatistics, V2, P85, DOI 10.1093/biostatistics/2.1.85